AMS - American Shared Hospital Services
NYSE
->
Healthcare
->
Medical Care Facilities
San Francisco,
United States
Type: Equity
AMS price evolution
AMS
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $9.94 | $10.1 | $6.99 | $4.85 |
| Inventory | ||||
| Total current assets | $25.72 | $25.64 | $21.36 | $20.46 |
| Long term investments | ||||
| Property, plant & equipment | $35.81 | $33.64 | $26.93 | $25.92 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $63.27 | $60.83 | $50.12 | $48.16 |
| Current liabilities | ||||
| Accounts payable | $1.79 | $0.86 | $0.27 | $0.32 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $17.56 | $13.34 | $10.78 | $10.78 |
| Long term debt | $10.82 | $12.05 | $12.89 | $11.04 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $36.85 | $34.28 | $27.28 | $25.54 |
| Shareholders' equity | ||||
| Retained earnings | $7.14 | $7.35 | $3.75 | $3.63 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $4.33 | |||
| Short term investments | ||||
| Net receivables | $4.85 | $4.13 | $4.82 | $4.58 |
| Inventory | ||||
| Total current assets | $20.46 | $18.72 | $15.09 | $10.85 |
| Long term investments | ||||
| Property, plant & equipment | $25.92 | $23.8 | $28.93 | $30.44 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $32.8 | |||
| Total investments | ||||
| Total assets | $48.16 | $43.96 | $45.43 | $43.65 |
| Current liabilities | ||||
| Accounts payable | $0.32 | $0.23 | $0.75 | $0.68 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $10.78 | $5.17 | $5.89 | $12.38 |
| Long term debt | $11.04 | $12.21 | $14.32 | $3.44 |
| Total noncurrent liabilities | $7.62 | |||
| Total debt | ||||
| Total liabilities | $25.54 | $22.33 | $25.54 | $20 |
| Shareholders' equity | ||||
| Retained earnings | $3.63 | $3.02 | $1.69 | $1.5 |
| Other shareholder equity | $4.38 | |||
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $7.06 | $5.22 | $5.7 | |
| Cost of revenue | ||||
| Gross Profit | $2.47 | $2.14 | $2.82 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $1.9 | $1.88 | $1.76 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0.03 | -$0.04 | $0.34 | |
| Interest expense | -$0.33 | -$0.24 | -$0.18 | |
| Net income | ||||
| Net income | $3.6 | $0.12 | $0.41 | |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $21.32 | $19.75 | $17.63 | $17.84 |
| Cost of revenue | ||||
| Gross Profit | $9.34 | $8.38 | $6.73 | $4.47 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $7.02 | $5.15 | $4.53 | $14.3 |
| Operating income | -$9.46 | |||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.43 | $0.96 | $0.27 | -$1.74 |
| Interest expense | -$0.69 | -$0.72 | -$0.74 | $1.06 |
| Net income | ||||
| Net income | $0.61 | $1.33 | $0.19 | -$7.06 |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$2.74 | -$2.04 | -$1.18 | -$6.27 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $3.12 | $3.29 | $2.28 | $1.91 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.27 | $0.68 | -$0.77 | $1.36 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Net income | -$7.72 | |||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $9.74 | |||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$6.27 | -$0.39 | -$1.67 | -$2.39 |
| Financing activities | ||||
| Dividends paid | -$0.76 | |||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $1.91 | -$2.66 | -$0.66 | -$4.81 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $1.36 | $4.19 | $3.94 | $2.55 |
News
Fundamentals
| Market cap | $20.00M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 6.39M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.46 |
| Quick ratio | N/A |